Plasma hormone levels and the incidence of carcinogen-induced mammary tumours in two strains of rat
- PMID: 826265
- PMCID: PMC2025204
- DOI: 10.1038/bjc.1976.209
Plasma hormone levels and the incidence of carcinogen-induced mammary tumours in two strains of rat
Abstract
The incidence of mammary tumours developing after administration of the carcinogen DMBA (at 50 days of age) has been determined in 2 strains of Sprague-Dawley rat. Untreated animals of each strain were exsanguinated in dioestrus at a time corresponding to the early post-carcinogen stage (at 70 days of age) and the plasma concentrations of prolactin, oestradiol-17B and progesterone were measured by radioimmunoassay. In an inbred strain of rats, tumour-induction rate was 6-4% and plasma prolactin concentration was 2-5 x lower than that found in a random-bred strain with a tumour-induction rate of 41-6%. No difference was found between the 2 strains in the level of either ovarian hormone. It is concluded that the difference between these strains in mammary gland susceptibility to DMBA may be related to plasma prolactin concentration, but it is unlikely to be determined by the ovarian hormones.
Similar articles
-
Prolactin levels and molecular heterogeneity in rat strains with high and low incidence of DMBA-induced mammary tumors.Breast Cancer Res Treat. 1984;4(2):129-36. doi: 10.1007/BF01806395. Breast Cancer Res Treat. 1984. PMID: 6430370
-
Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.Cancer Res. 1981 Nov;41(11 Pt 1):4432-6. Cancer Res. 1981. PMID: 6796259
-
The prophylaxis of rat and mouse mammary gland tumorigenesis by suppression of prolactin secretion: a reappraisal.Breast Cancer Res Treat. 1981;1(3):225-32. doi: 10.1007/BF01806262. Breast Cancer Res Treat. 1981. PMID: 6816317
-
Experimentally induced mammary tumors in rats.Breast Cancer Res Treat. 1996;39(1):7-20. doi: 10.1007/BF01806074. Breast Cancer Res Treat. 1996. PMID: 8738602 Review.
-
Early indicators for carcinogenesis in sex-hormone-sensitive organs.Mutat Res. 1991 Jun;248(2):341-56. doi: 10.1016/0027-5107(91)90067-x. Mutat Res. 1991. PMID: 2046690 Review.
Cited by
-
Endocrinologic milieu and susceptibility of the rat mammary gland to carcinogenesis.Am J Pathol. 1982 Oct;109(1):47-56. Am J Pathol. 1982. PMID: 6812428 Free PMC article.
-
Prolactin concentration in plasma and susceptibility to mammary tumors in female rats from different strains treated chronically with estradiol-17 beta.Breast Cancer Res Treat. 1984;4(2):137-41. doi: 10.1007/BF01806396. Breast Cancer Res Treat. 1984. PMID: 6743839
-
Prolactin levels and molecular heterogeneity in rat strains with high and low incidence of DMBA-induced mammary tumors.Breast Cancer Res Treat. 1984;4(2):129-36. doi: 10.1007/BF01806395. Breast Cancer Res Treat. 1984. PMID: 6430370
-
Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis.Environ Health Perspect. 1983 Mar;49:185-99. doi: 10.1289/ehp.8349185. Environ Health Perspect. 1983. PMID: 6403347 Free PMC article. Review.
-
Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo.J Cancer Res Clin Oncol. 1991;117(6):526-32. doi: 10.1007/BF01613283. J Cancer Res Clin Oncol. 1991. PMID: 1744157 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources